{"transactions":[{"id":2268,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2026-09-03T20:17:38.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":2768,"price":23.44,"value":64881.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 135,475 Unvested RSUs."}],"balance_after":278995,"source":{"system":"sec-edgar","filing":"0001724311-26-000014","document":"wk-form4_1788466654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000172431126000014/wk-form4_1788466654.xml","form_type":"4"}},{"id":688020,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2026-08-13T21:01:59.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":2857,"price":25.07,"value":71624.99,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 135,475 Unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,792 shares acquired under the ESPP Purchase on June 1, 2026."}],"balance_after":281763,"source":{"system":"sec-edgar","filing":"0001724311-26-000013","document":"wk-form4_1786654917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000172431126000013/wk-form4_1786654917.xml","form_type":"4"}},{"id":943259,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2026-01-08T21:19:45.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":17218,"price":16.5,"value":284097.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 141,100 Unvested RSUs."}],"balance_after":282828,"source":{"system":"sec-edgar","filing":"0001724311-26-000005","document":"wk-form4_1767907181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000172431126000005/wk-form4_1767907181.xml","form_type":"4"}},{"id":951628,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T23:49:12.000Z","date":"2026-01-03","kind":"grant","planned":false,"acquired":true,"shares":173100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2027, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":173100,"derivative":{"exercise_price":16.27,"expiration_date":"2036-01-03","underlying":"Common Stock","underlying_shares":173100},"source":{"system":"sec-edgar","filing":"0001724311-26-000001","document":"wk-form4_1767656950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000172431126000001/wk-form4_1767656950.xml","form_type":"4"}},{"id":951627,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2026-01-05T23:49:12.000Z","date":"2026-01-03","kind":"grant","planned":false,"acquired":true,"shares":57700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2027 (the \"Vesting\nCommencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service\nprovider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 141,100 Unvested RSUs."}],"balance_after":300046,"source":{"system":"sec-edgar","filing":"0001724311-26-000001","document":"wk-form4_1767656950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000172431126000001/wk-form4_1767656950.xml","form_type":"4"}},{"id":1066484,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2025-08-15T00:33:49.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":2937,"price":13.58,"value":39884.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.35 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a\nsecurity holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 128,405 Unvested RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 975 shares acquired under the ESPP Purchase on June 2, 2025."}],"balance_after":242346,"source":{"system":"sec-edgar","filing":"0001724311-25-000011","document":"wk-form4_1755218026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000172431125000011/wk-form4_1755218026.xml","form_type":"4"}},{"id":1306727,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2025-01-09T01:25:44.000Z","date":"2025-01-07","kind":"sale","planned":false,"acquired":false,"shares":2907,"price":20.81,"value":60494.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 134,030 Unvested RSUs."}],"balance_after":244308,"source":{"system":"sec-edgar","filing":"0001714899-25-000050","document":"wk-form4_1736385937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489925000050/wk-form4_1736385937.xml","form_type":"4"}},{"id":1306726,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2025-01-09T01:25:44.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":12255,"price":20.22,"value":247796.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 134,030 Unvested RSUs."}],"balance_after":247215,"source":{"system":"sec-edgar","filing":"0001714899-25-000050","document":"wk-form4_1736385937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489925000050/wk-form4_1736385937.xml","form_type":"4"}},{"id":1308124,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T23:57:55.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":162540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date"}],"balance_after":162540,"derivative":{"exercise_price":21.26,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":162540},"source":{"system":"sec-edgar","filing":"0001714899-25-000027","document":"wk-form4_1736294268.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489925000027/wk-form4_1736294268.xml","form_type":"4"}},{"id":1308123,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2025-01-07T23:57:55.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":54180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the \"Vesting\nCommencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service\nprovider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 141,530 Unvested RSUs."}],"balance_after":259470,"source":{"system":"sec-edgar","filing":"0001714899-25-000027","document":"wk-form4_1736294268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489925000027/wk-form4_1736294268.xml","form_type":"4"}},{"id":1319845,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-31T21:18:12.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":6708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter."}],"balance_after":46671,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":6708},"source":{"system":"sec-edgar","filing":"0001714899-24-000236","document":"wk-form4_1735679885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000236/wk-form4_1735679885.xml","form_type":"4"}},{"id":1319844,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-12-31T21:18:12.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":6708,"price":5.28,"value":35418.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 118,810 Unvested RSUs."}],"balance_after":205290,"source":{"system":"sec-edgar","filing":"0001714899-24-000236","document":"wk-form4_1735679885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000236/wk-form4_1735679885.xml","form_type":"4"}},{"id":1351019,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-26T22:19:27.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":false,"shares":20516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":124562,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":20516},"source":{"system":"sec-edgar","filing":"0001714899-24-000234","document":"wk-form4_1732659560.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000234/wk-form4_1732659560.xml","form_type":"4"}},{"id":1351018,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-11-26T22:19:27.000Z","date":"2024-11-22","kind":"exercise","planned":false,"acquired":true,"shares":20516,"price":0.68,"value":13950.88,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Includes 118,810 Unvested RSUs."}],"balance_after":198582,"source":{"system":"sec-edgar","filing":"0001714899-24-000234","document":"wk-form4_1732659560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000234/wk-form4_1732659560.xml","form_type":"4"}},{"id":1369045,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-12T21:44:51.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":false,"shares":15558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vest monthly thereafter."}],"balance_after":53379,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":15558},"source":{"system":"sec-edgar","filing":"0001714899-24-000218","document":"wk-form4_1731447884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000218/wk-form4_1731447884.xml","form_type":"4"}},{"id":1369044,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-11-12T21:44:51.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":300,"price":31.29,"value":9387.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.27 to $31.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 118,810 Unvested RSUs."}],"balance_after":178066,"source":{"system":"sec-edgar","filing":"0001714899-24-000218","document":"wk-form4_1731447884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000218/wk-form4_1731447884.xml","form_type":"4"}},{"id":1369043,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-11-12T21:44:51.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":2925,"price":30.72,"value":89856.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.21 to $31.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 118,810 Unvested RSUs."}],"balance_after":178366,"source":{"system":"sec-edgar","filing":"0001714899-24-000218","document":"wk-form4_1731447884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000218/wk-form4_1731447884.xml","form_type":"4"}},{"id":1369042,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-11-12T21:44:51.000Z","date":"2024-11-07","kind":"sale","planned":true,"acquired":false,"shares":12333,"price":29.68,"value":366043.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.21 to $30.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 118,810 Unvested RSUs."}],"balance_after":181291,"source":{"system":"sec-edgar","filing":"0001714899-24-000218","document":"wk-form4_1731447884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000218/wk-form4_1731447884.xml","form_type":"4"}},{"id":1369041,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-11-12T21:44:51.000Z","date":"2024-11-07","kind":"exercise","planned":true,"acquired":true,"shares":15558,"price":5.28,"value":82146.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 118,810 Unvested RSUs."}],"balance_after":193624,"source":{"system":"sec-edgar","filing":"0001714899-24-000218","document":"wk-form4_1731447884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000218/wk-form4_1731447884.xml","form_type":"4"}},{"id":1425361,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-08-22T20:14:40.000Z","date":"2024-08-21","kind":"sale","planned":true,"acquired":false,"shares":2547,"price":24.78,"value":63114.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.19 to $25.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 118,810 Unvested RSUs."}],"balance_after":178066,"source":{"system":"sec-edgar","filing":"0001714899-24-000195","document":"wk-form4_1724357674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000195/wk-form4_1724357674.xml","form_type":"4"}},{"id":1425360,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-08-22T20:14:40.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":3353,"price":23.54,"value":78929.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.38 to $23.72 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 118,810 Unvested RSUs."}],"balance_after":180613,"source":{"system":"sec-edgar","filing":"0001714899-24-000195","document":"wk-form4_1724357674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000195/wk-form4_1724357674.xml","form_type":"4"}},{"id":1425359,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-08-22T20:14:40.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":2453,"price":23.79,"value":58356.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 118,810 Unvested RSUs."}],"balance_after":183966,"source":{"system":"sec-edgar","filing":"0001714899-24-000195","document":"wk-form4_1724357674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000195/wk-form4_1724357674.xml","form_type":"4"}},{"id":1432575,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-08-15T20:10:01.000Z","date":"2024-08-13","kind":"sale","planned":false,"acquired":false,"shares":2272,"price":22.89,"value":52006.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 123,810 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,350 shares acquired under the ESPP Purchase on May 31, 2024."}],"balance_after":186419,"source":{"system":"sec-edgar","filing":"0001714899-24-000177","document":"wk-form4_1723752595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000177/wk-form4_1723752595.xml","form_type":"4"}},{"id":1641017,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-02-16T02:14:01.000Z","date":"2024-02-14","kind":"sale","planned":true,"acquired":false,"shares":20128,"price":17.66,"value":355460.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 129,435 RSUs."}],"balance_after":187341,"source":{"system":"sec-edgar","filing":"0001714899-24-000059","document":"wk-form4_1708049627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000059/wk-form4_1708049627.xml","form_type":"4"}},{"id":1641016,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-02-16T02:14:01.000Z","date":"2024-02-13","kind":"sale","planned":true,"acquired":false,"shares":2716,"price":17.29,"value":46959.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $17.08 to $17.30 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 129,435 RSUs."}],"balance_after":207469,"source":{"system":"sec-edgar","filing":"0001714899-24-000059","document":"wk-form4_1708049627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000059/wk-form4_1708049627.xml","form_type":"4"}},{"id":1649370,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-12T21:48:27.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":145078,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001714899-24-000042","document":"wk-form4_1707774481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000042/wk-form4_1707774481.xml","form_type":"4"}},{"id":1649369,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-02-12T21:48:27.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.68,"value":34000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 136,721 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 15,558 shares previously disclosed as held indirectly; but have been determined to be held directly."}],"balance_after":210185,"source":{"system":"sec-edgar","filing":"0001714899-24-000042","document":"wk-form4_1707774481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000042/wk-form4_1707774481.xml","form_type":"4"}},{"id":1682765,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-01-10T00:34:07.000Z","date":"2024-01-05","kind":"sale","planned":false,"acquired":false,"shares":9972,"price":19.43,"value":193755.96,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.36 to $19.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 25,530 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":539307,"source":{"system":"sec-edgar","filing":"0001714899-24-000036","document":"wk-form4_1704846835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000036/wk-form4_1704846835.xml","form_type":"4"}},{"id":1685561,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T22:57:45.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":161160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option shall vest on January 3, 2025, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider\nof the Issuer through each such date."}],"balance_after":161160,"derivative":{"exercise_price":20.33,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":161160},"source":{"system":"sec-edgar","filing":"0001714899-24-000010","document":"wk-form4_1704495454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000010/wk-form4_1704495454.xml","form_type":"4"}},{"id":1685560,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2024-01-05T22:57:45.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":53720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2025 (the \"Vesting\nCommencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of\nthe Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 136,721 RSU's as of January 4, 2024."}],"balance_after":170157,"source":{"system":"sec-edgar","filing":"0001714899-24-000010","document":"wk-form4_1704495454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489924000010/wk-form4_1704495454.xml","form_type":"4"}},{"id":1796398,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-08-25T21:36:53.000Z","date":"2023-08-23","kind":"sale","planned":false,"acquired":false,"shares":2522,"price":23.17,"value":58434.74,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.87 to $23.36 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the\nIssuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":518989,"source":{"system":"sec-edgar","filing":"0001714899-23-000137","document":"wk-form4_1692999400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000137/wk-form4_1692999400.xml","form_type":"4"}},{"id":1798724,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-08-23T20:33:37.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":2478,"price":22.59,"value":55978.02,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.49 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a securityholder of\nthe Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 5,000 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":521511,"source":{"system":"sec-edgar","filing":"0001714899-23-000134","document":"wk-form4_1692822802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000134/wk-form4_1692822802.xml","form_type":"4"}},{"id":1805925,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-08-16T22:19:14.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":2772,"price":23.67,"value":65613.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.58 to $23.80 per share. Upon request by the Commission staff, the Issuer, or a securityholder of\nthe Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":518989,"source":{"system":"sec-edgar","filing":"0001714899-23-000124","document":"wk-form4_1692224345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000124/wk-form4_1692224345.xml","form_type":"4"}},{"id":1808631,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-08-14T21:11:36.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":2853,"price":24.18,"value":68985.54,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":". The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.99 to $24.35 per share. Upon request by the Commission staff, the Issuer, or a\nsecurityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 5,625 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":521761,"source":{"system":"sec-edgar","filing":"0001714899-23-000121","document":"wk-form4_1692047483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000121/wk-form4_1692047483.xml","form_type":"4"}},{"id":1826909,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T21:10:17.000Z","date":"2023-07-17","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter."}],"balance_after":68937,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001714899-23-000109","document":"wk-form4_1689801007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000109/wk-form4_1689801007.xml","form_type":"4"}},{"id":1826908,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-07-19T21:10:17.000Z","date":"2023-07-18","kind":"sale","planned":false,"acquired":false,"shares":9702,"price":30.01,"value":291157.02,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.00 to $30.04 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":518989,"source":{"system":"sec-edgar","filing":"0001714899-23-000109","document":"wk-form4_1689801007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000109/wk-form4_1689801007.xml","form_type":"4"}},{"id":1826907,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-07-19T21:10:17.000Z","date":"2023-07-17","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":29.6,"value":296000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.33 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a\nsecurityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":528691,"source":{"system":"sec-edgar","filing":"0001714899-23-000109","document":"wk-form4_1689801007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000109/wk-form4_1689801007.xml","form_type":"4"}},{"id":1826906,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-07-19T21:10:17.000Z","date":"2023-07-17","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":5.28,"value":52800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":538691,"source":{"system":"sec-edgar","filing":"0001714899-23-000109","document":"wk-form4_1689801007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000109/wk-form4_1689801007.xml","form_type":"4"}},{"id":1889135,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-05-17T20:56:57.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter."}],"balance_after":78937,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001714899-23-000076","document":"wf-form4_168435700588836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000076/wf-form4_168435700588836.xml","form_type":"4"}},{"id":1889134,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-05-17T20:56:57.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":800,"price":29.23,"value":23384.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.20 to $29.25 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":528691,"source":{"system":"sec-edgar","filing":"0001714899-23-000076","document":"wf-form4_168435700588836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000076/wf-form4_168435700588836.xml","form_type":"4"}},{"id":1889133,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-05-17T20:56:57.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":9200,"price":28.55,"value":262660.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.15 to $29.07 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":529491,"source":{"system":"sec-edgar","filing":"0001714899-23-000076","document":"wf-form4_168435700588836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000076/wf-form4_168435700588836.xml","form_type":"4"}},{"id":1889132,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-05-17T20:56:57.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":5.28,"value":52800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":538691,"source":{"system":"sec-edgar","filing":"0001714899-23-000076","document":"wf-form4_168435700588836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000076/wf-form4_168435700588836.xml","form_type":"4"}},{"id":1919617,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T22:27:13.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":4898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter."}],"balance_after":88937,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":4898},"source":{"system":"sec-edgar","filing":"0001714899-23-000055","document":"wf-form4_168151121787982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000055/wf-form4_168151121787982.xml","form_type":"4"}},{"id":1919616,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T22:27:13.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":false,"shares":5102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter."}],"balance_after":93835,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":5102},"source":{"system":"sec-edgar","filing":"0001714899-23-000055","document":"wf-form4_168151121787982.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000055/wf-form4_168151121787982.xml","form_type":"4"}},{"id":1919615,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-04-14T22:27:13.000Z","date":"2023-04-13","kind":"sale","planned":false,"acquired":false,"shares":4898,"price":25.04,"value":122645.92,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $25.00 to $25.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":528691,"source":{"system":"sec-edgar","filing":"0001714899-23-000055","document":"wf-form4_168151121787982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000055/wf-form4_168151121787982.xml","form_type":"4"}},{"id":1919614,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-04-14T22:27:13.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":4898,"price":5.28,"value":25861.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":533589,"source":{"system":"sec-edgar","filing":"0001714899-23-000055","document":"wf-form4_168151121787982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000055/wf-form4_168151121787982.xml","form_type":"4"}},{"id":1919613,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-04-14T22:27:13.000Z","date":"2023-04-12","kind":"sale","planned":false,"acquired":false,"shares":5102,"price":25.04,"value":127754.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $25.00 to $25.49 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":528691,"source":{"system":"sec-edgar","filing":"0001714899-23-000055","document":"wf-form4_168151121787982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000055/wf-form4_168151121787982.xml","form_type":"4"}},{"id":1919612,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-04-14T22:27:13.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":true,"shares":5102,"price":5.28,"value":26938.56,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":533793,"source":{"system":"sec-edgar","filing":"0001714899-23-000055","document":"wf-form4_168151121787982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000055/wf-form4_168151121787982.xml","form_type":"4"}},{"id":2013654,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-16T00:01:53.000Z","date":"2023-02-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days."}],"balance_after":195078,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001714899-23-000030","document":"wf-form4_167650569228111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000030/wf-form4_167650569228111.xml","form_type":"4"}},{"id":2013653,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-02-16T00:01:53.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":3497,"price":30.09,"value":105224.73,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.92 to $30.24 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,286 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":528691,"source":{"system":"sec-edgar","filing":"0001714899-23-000030","document":"wf-form4_167650569228111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000030/wf-form4_167650569228111.xml","form_type":"4"}},{"id":2013652,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-02-16T00:01:53.000Z","date":"2023-02-13","kind":"exercise","acquired":true,"shares":25000,"price":0.68,"value":17000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":524902,"source":{"system":"sec-edgar","filing":"0001714899-23-000030","document":"wf-form4_167650569228111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000030/wf-form4_167650569228111.xml","form_type":"4"}},{"id":2022795,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-02-10T23:11:39.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":1521,"price":30.89,"value":46983.69,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $30.78 to $31.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 4,250 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":499902,"source":{"system":"sec-edgar","filing":"0001714899-23-000020","document":"wf-form4_167607068513350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000020/wf-form4_167607068513350.xml","form_type":"4"}},{"id":2050938,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-19T22:09:36.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vested on March 8, 2018 and an additional 1/48 of the shares vested monthly thereafter."}],"balance_after":98937,"derivative":{"exercise_price":5.28,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001714899-23-000018","document":"wf-form4_167416615634275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000018/wf-form4_167416615634275.xml","form_type":"4"}},{"id":2050937,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-19T22:09:36.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":114,"price":29.87,"value":3405.18,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":497173,"source":{"system":"sec-edgar","filing":"0001714899-23-000018","document":"wf-form4_167416615634275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000018/wf-form4_167416615634275.xml","form_type":"4"}},{"id":2050936,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-19T22:09:36.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":9886,"price":29.53,"value":291933.58,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.87 to $29.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":497287,"source":{"system":"sec-edgar","filing":"0001714899-23-000018","document":"wf-form4_167416615634275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000018/wf-form4_167416615634275.xml","form_type":"4"}},{"id":2050935,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-19T22:09:36.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":10000,"price":5.28,"value":52800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":507173,"source":{"system":"sec-edgar","filing":"0001714899-23-000018","document":"wf-form4_167416615634275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000018/wf-form4_167416615634275.xml","form_type":"4"}},{"id":2058911,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-10T02:41:58.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":2636,"price":28.44,"value":74967.84,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.17 to $28.68 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,500 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":497173,"source":{"system":"sec-edgar","filing":"0001714899-23-000014","document":"wf-form4_167331850392461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489923000014/wf-form4_167331850392461.xml","form_type":"4"}},{"id":2058910,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-09T21:05:49.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":2912,"price":28.7,"value":83574.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":492309,"source":{"system":"sec-edgar","filing":"0001209191-23-002545","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919123002545/doc4a.xml","form_type":"4/A","original_submission_date":"2023-01-05"}},{"id":2062836,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-06T02:07:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":123360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option shall vest on January 3, 2024, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":123360,"derivative":{"exercise_price":27.63,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":123360},"source":{"system":"sec-edgar","filing":"0001209191-23-002181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919123002181/doc4.xml","form_type":"4"}},{"id":2062835,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-06T02:07:47.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":2912,"price":28.7,"value":83574.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 138,192 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person."}],"balance_after":149828,"source":{"system":"sec-edgar","filing":"0001209191-23-002181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919123002181/doc4.xml","form_type":"4"}},{"id":2062834,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2023-01-06T02:07:47.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":41120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2024 (the \"Vesting Commencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 138,192 RSUs."}],"balance_after":157578,"source":{"system":"sec-edgar","filing":"0001209191-23-002181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919123002181/doc4.xml","form_type":"4"}},{"id":2138335,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-10-12T20:05:35.000Z","date":"2022-10-07","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018."}],"balance_after":220078,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001714899-22-000135","document":"wf-form4_166560511822999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000135/wf-form4_166560511822999.xml","form_type":"4"}},{"id":2138334,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2022-10-12T20:05:35.000Z","date":"2022-10-07","kind":"exercise","acquired":true,"shares":20000,"price":0.68,"value":13600.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Exercised shares were issued to the Schuth Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":487471,"source":{"system":"sec-edgar","filing":"0001714899-22-000135","document":"wf-form4_166560511822999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000135/wf-form4_166560511822999.xml","form_type":"4"}},{"id":2176142,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2022-08-23T20:46:50.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":2576,"price":33.22,"value":85574.72,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.11 to $33.38 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 5,000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":467471,"source":{"system":"sec-edgar","filing":"0001714899-22-000127","document":"wf-form4_166128759380161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000127/wf-form4_166128759380161.xml","form_type":"4"}},{"id":2188183,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COFO and Secretary"}}],"security":"Common Stock","published_at":"2022-08-11T23:21:00.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on August 9, 2023 (the\"Vesting Commencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a serviceprovider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 109,822 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 540 shares acquired under the ESPP Purchase on May 31, 2022."}],"balance_after":121458,"source":{"system":"sec-edgar","filing":"0001714899-22-000124","document":"wf-form4_166026004225336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000124/wf-form4_166026004225336.xml","form_type":"4"}},{"id":2394621,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2022-02-15T23:55:23.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":2803,"price":34.68,"value":97208.04,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $34.42 to $35.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 7,286 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":465047,"source":{"system":"sec-edgar","filing":"0001714899-22-000040","document":"wf-form4_164496930840504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000040/wf-form4_164496930840504.xml","form_type":"4"}},{"id":2401838,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2022-02-11T22:18:12.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":1423,"price":37.1045,"value":52799.7035,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $36.71 to $37.40 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 4250 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":460564,"source":{"system":"sec-edgar","filing":"0001714899-22-000034","document":"wf-form4_164461787567236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000034/wf-form4_164461787567236.xml","form_type":"4"}},{"id":2440148,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2022-01-07T23:05:33.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":2846,"price":44.77,"value":127415.42,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.44 to $45.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 7500 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":457737,"source":{"system":"sec-edgar","filing":"0001714899-22-000005","document":"wf-form4_164159671916562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000005/wf-form4_164159671916562.xml","form_type":"4"}},{"id":2444116,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:04:03.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 3, 2023, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":93000,"derivative":{"exercise_price":47.27,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001714899-22-000004","document":"wf-form4_164142742987933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000004/wf-form4_164142742987933.xml","form_type":"4"}},{"id":2444115,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2022-01-06T00:04:03.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a Restricted Stock Unit (\"RSU\") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2023 (the \"Vesting Commencement Date\") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 106,358 restricted stock units."}],"balance_after":117454,"source":{"system":"sec-edgar","filing":"0001714899-22-000004","document":"wf-form4_164142742987933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489922000004/wf-form4_164142742987933.xml","form_type":"4"}},{"id":2480699,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-12-08T22:35:42.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":7200,"price":42.45,"value":305640.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $42.21 to $42.91 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":453083,"source":{"system":"sec-edgar","filing":"0001714899-21-000116","document":"wf-form4_163900292998153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000116/wf-form4_163900292998153.xml","form_type":"4"}},{"id":2480698,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-12-08T22:35:42.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":2800,"price":41.82,"value":117096.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $41.16 to $42.14 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":460283,"source":{"system":"sec-edgar","filing":"0001714899-21-000116","document":"wf-form4_163900292998153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000116/wf-form4_163900292998153.xml","form_type":"4"}},{"id":2521490,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-11-08T21:16:17.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":3283,"price":53.23,"value":174754.09,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $52.94 to $53.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":463083,"source":{"system":"sec-edgar","filing":"0001714899-21-000107","document":"wf-form4_163640615125307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000107/wf-form4_163640615125307.xml","form_type":"4"}},{"id":2521489,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-11-08T21:16:17.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":6717,"price":52.65,"value":353650.05,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $51.93 to $52.88 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":466366,"source":{"system":"sec-edgar","filing":"0001714899-21-000107","document":"wf-form4_163640615125307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000107/wf-form4_163640615125307.xml","form_type":"4"}},{"id":2547236,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-10-06T22:14:03.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":4006,"price":51.04,"value":204466.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $50.64 to $51.3350 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Restated to accurately report holdings that were misallocated in the Reporting Person's previous Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":473083,"source":{"system":"sec-edgar","filing":"0001714899-21-000094","document":"wf-form4_163355842818926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000094/wf-form4_163355842818926.xml","form_type":"4"}},{"id":2547235,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-10-06T22:14:03.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":5994,"price":50.24,"value":301138.56,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $49.6350 to $50.6275 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Restated to accurately report holdings that were misallocated in the Reporting Person's previous Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":477089,"source":{"system":"sec-edgar","filing":"0001714899-21-000094","document":"wf-form4_163355842818926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000094/wf-form4_163355842818926.xml","form_type":"4"}},{"id":2562040,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-22T22:06:43.000Z","date":"2021-09-20","kind":"exercise","acquired":false,"shares":9045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics.  50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018."}],"balance_after":240078,"derivative":{"exercise_price":0.68,"expiration_date":"2025-08-20","underlying":"Common Stock","underlying_shares":9045},"source":{"system":"sec-edgar","filing":"0001714899-21-000092","document":"wf-form4_163234839118824.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000092/wf-form4_163234839118824.xml","form_type":"4"}},{"id":2562039,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-09-22T22:06:43.000Z","date":"2021-09-20","kind":"exercise","acquired":true,"shares":9045,"price":0.68,"value":6150.6,"ownership":{"direct":true},"balance_after":95499,"source":{"system":"sec-edgar","filing":"0001714899-21-000092","document":"wf-form4_163234839118824.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000092/wf-form4_163234839118824.xml","form_type":"4"}},{"id":2574843,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-09-09T21:08:49.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":2441,"price":56.05,"value":136818.05,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $56.00 to $56.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":474038,"source":{"system":"sec-edgar","filing":"0001714899-21-000090","document":"wf-form4_163122171523267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000090/wf-form4_163122171523267.xml","form_type":"4"}},{"id":2574842,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-09-09T21:08:49.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":5350,"price":55.67,"value":297834.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $55.01 to $55.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":476479,"source":{"system":"sec-edgar","filing":"0001714899-21-000090","document":"wf-form4_163122171523267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000090/wf-form4_163122171523267.xml","form_type":"4"}},{"id":2574841,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-09-09T21:08:49.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":2209,"price":54.7,"value":120832.3,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $54.01 to $55.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":481829,"source":{"system":"sec-edgar","filing":"0001714899-21-000090","document":"wf-form4_163122171523267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000090/wf-form4_163122171523267.xml","form_type":"4"}},{"id":2593574,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-08-24T00:25:32.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":196,"price":50.1,"value":9819.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $50.08 to $50.12 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":484038,"source":{"system":"sec-edgar","filing":"0001714899-21-000086","document":"wf-form4_162976470516097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000086/wf-form4_162976470516097.xml","form_type":"4"}},{"id":2593573,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-08-24T00:25:32.000Z","date":"2021-08-19","kind":"sale","acquired":false,"shares":2348,"price":49.56,"value":116366.88,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $49.08 to $50.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 5000 restricted stock units held by the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":484234,"source":{"system":"sec-edgar","filing":"0001714899-21-000086","document":"wf-form4_162976470516097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000086/wf-form4_162976470516097.xml","form_type":"4"}},{"id":2611551,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-08-06T20:09:51.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":200,"price":52.99,"value":10598.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":481582,"source":{"system":"sec-edgar","filing":"0001714899-21-000082","document":"wf-form4_162828056411896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000082/wf-form4_162828056411896.xml","form_type":"4"}},{"id":2611550,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-08-06T20:09:51.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":8236,"price":52.339,"value":431064.004,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $51.93 to $52.84 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":481782,"source":{"system":"sec-edgar","filing":"0001714899-21-000082","document":"wf-form4_162828056411896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000082/wf-form4_162828056411896.xml","form_type":"4"}},{"id":2611549,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-08-06T20:09:51.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":1564,"price":51.516,"value":80571.024,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $50.93 to $51.92 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":490018,"source":{"system":"sec-edgar","filing":"0001714899-21-000082","document":"wf-form4_162828056411896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000171489921000082/wf-form4_162828056411896.xml","form_type":"4"}},{"id":2638127,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-07-08T20:06:31.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":10000,"price":76.204,"value":762040.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $75.68 to $76.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":491582,"source":{"system":"sec-edgar","filing":"0001209191-21-045986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121045986/doc4.xml","form_type":"4"}},{"id":2677757,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-06-08T21:10:20.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":4340,"price":64.816,"value":281301.44,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $64.70 to $64.91 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":501582,"source":{"system":"sec-edgar","filing":"0001209191-21-038977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121038977/doc4.xml","form_type":"4"}},{"id":2677756,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-06-08T21:10:20.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":5660,"price":64.346,"value":364198.36,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $63.70 to $64.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":505922,"source":{"system":"sec-edgar","filing":"0001209191-21-038977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121038977/doc4.xml","form_type":"4"}},{"id":2725189,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-05-06T22:50:19.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":445,"price":57.39,"value":25538.55,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $56.80 to $57.54 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":511582,"source":{"system":"sec-edgar","filing":"0001209191-21-030724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121030724/doc4.xml","form_type":"4"}},{"id":2725188,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-05-06T22:50:19.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":3557,"price":55.915,"value":198889.655,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $55.55 to $56.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":512027,"source":{"system":"sec-edgar","filing":"0001209191-21-030724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121030724/doc4.xml","form_type":"4"}},{"id":2725187,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-05-06T22:50:19.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":5998,"price":55.091,"value":330435.818,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $54.52 to $55.50 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":515584,"source":{"system":"sec-edgar","filing":"0001209191-21-030724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121030724/doc4.xml","form_type":"4"}},{"id":2755851,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-04-07T00:39:17.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":700,"price":57.437,"value":40205.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $57.11 to $57.86 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":521582,"source":{"system":"sec-edgar","filing":"0001209191-21-025768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121025768/doc4.xml","form_type":"4"}},{"id":2755850,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-04-07T00:39:17.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":4156,"price":56.465,"value":234668.54,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $56.10 to $57.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":522282,"source":{"system":"sec-edgar","filing":"0001209191-21-025768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121025768/doc4.xml","form_type":"4"}},{"id":2755849,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-04-07T00:39:17.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":5144,"price":55.604,"value":286026.976,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $55.10 to $56.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":526438,"source":{"system":"sec-edgar","filing":"0001209191-21-025768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121025768/doc4.xml","form_type":"4"}},{"id":2809047,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-03-04T23:38:33.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":1878,"price":61.58,"value":115647.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $61.375 to $62.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":531582,"source":{"system":"sec-edgar","filing":"0001209191-21-017983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121017983/doc4.xml","form_type":"4"}},{"id":2809046,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-03-04T23:38:33.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":8122,"price":60.887,"value":494524.214,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $60.37 to $61.325 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":533460,"source":{"system":"sec-edgar","filing":"0001209191-21-017983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121017983/doc4.xml","form_type":"4"}},{"id":2859322,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-02-17T00:43:00.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":433,"price":71.408,"value":30919.664,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $70.87 to $71.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,285 shares acquired pursuant to vesting of restricted stock units and issued directly to the Schuth Family Trust U/A DTD 06/05/2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":541582,"source":{"system":"sec-edgar","filing":"0001209191-21-011008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121011008/doc4.xml","form_type":"4"}},{"id":2859321,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Common Stock","published_at":"2021-02-17T00:43:00.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":2614,"price":70.169,"value":183421.766,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $69.80 to $70.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,285 shares acquired pursuant to vesting of restricted stock units and issued directly to the Schuth Family Trust U/A DTD 06/05/2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee."}],"balance_after":542015,"source":{"system":"sec-edgar","filing":"0001209191-21-011008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121011008/doc4.xml","form_type":"4"}},{"id":2866780,"issuer":{"id":1735,"kind":"organization","name":"Denali Therapeutics Inc.","symbol":"DNLI"},"owners":[{"id":1736,"kind":"person","name":"Schuth Alexander O.","position":1,"cik":"0001724311","reported_name":"Schuth Alexander O.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-02-12T00:13:12.000Z","date":"2021-02-07","kind":"exercise","acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the restricted stock units vested on February 7, 2020 (the \"Vesting Commencement Date\") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"25% of the restricted stock units vested on February 7, 2020 (the \"Vesting Commencement Date\") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date."}],"balance_after":8500,"derivative":{"underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-21-009892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724311/000120919121009892/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-12T00:13:12.000000Z,2866780"}